Envestnet Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.78M | Buy |
169,954
+17,791
| +12% | +$425K | ﹤0.01% | 2540 |
|
|
2025
Q4 | $4.06M | Buy |
152,163
+2,518
| +2% | +$60.2K | ﹤0.01% | 2323 |
|
|
2025
Q3 | $3.19M | Sell |
149,645
-12,997
| -8% | -$307K | ﹤0.01% | 2559 |
|
|
2025
Q2 | $3.51M | Buy |
162,642
+19,975
| +14% | +$371K | ﹤0.01% | 2455 |
|
|
2025
Q1 | $2.37M | Buy |
142,667
+36,003
| +34% | +$654K | ﹤0.01% | 2608 |
|
|
2024
Q4 | $1.96M | Sell |
106,664
-12,037
| -10% | -$194K | ﹤0.01% | 2694 |
|
|
2024
Q3 | $1.83M | Buy |
118,701
+11,158
| +10% | +$186K | ﹤0.01% | 2720 |
|
|
2024
Q2 | $1.75M | Buy |
107,543
+1,964
| +2% | +$31.7K | ﹤0.01% | 2674 |
|
|
2024
Q1 | $1.95M | Sell |
105,579
-45,353
| -30% | -$1.12M | ﹤0.01% | 2586 |
|
|
2023
Q4 | $4.73M | Sell |
150,932
-20,883
| -12% | -$499K | ﹤0.01% | 1938 |
|
|
2023
Q3 | $3.58M | Buy |
171,815
+79,298
| +86% | +$2.15M | ﹤0.01% | 2020 |
|
|
2023
Q2 | $2.22M | Buy |
92,517
+27,821
| +43% | +$618K | ﹤0.01% | 2222 |
|
|
2023
Q1 | $1.22M | Buy |
64,696
+10,206
| +19% | +$194K | ﹤0.01% | 2539 |
|
|
2022
Q4 | $867K | Sell |
54,490
-4,212
| -7% | -$65.8K | ﹤0.01% | 2753 |
|
|
2022
Q3 | $960K | Sell |
58,702
-4,548
| -7% | -$73.7K | ﹤0.01% | 2601 |
|
|
2022
Q2 | $891K | Sell |
63,250
-7,936
| -11% | -$148K | ﹤0.01% | 2686 |
|
|
2022
Q1 | $1.72M | Sell |
71,186
-6,441
| -8% | -$156K | ﹤0.01% | 2296 |
|
|
2021
Q4 | $1.81M | Sell |
77,627
-24,876
| -24% | -$500K | ﹤0.01% | 2243 |
|
|
2021
Q3 | $1.7M | Sell |
102,503
-2,390
| -2% | -$46.1K | ﹤0.01% | 2190 |
|
|
2021
Q2 | $2.56M | Buy |
104,893
+3,513
| +3% | +$79.3K | ﹤0.01% | 1904 |
|
|
2021
Q1 | $2.62M | Buy |
101,380
+79,483
| +363% | +$3.5M | ﹤0.01% | 1783 |
|
|
2020
Q4 | $1.17M | Buy |
21,897
+3,250
| +17% | +$161K | ﹤0.01% | 2098 |
|
|
2020
Q3 | $769K | Buy |
18,647
+2,683
| +17% | +$116K | ﹤0.01% | 2184 |
|
|
2020
Q2 | $774K | Buy |
15,964
+120
| +0.8% | +$5.76K | ﹤0.01% | 2119 |
|
|
2020
Q1 | $669K | Buy |
15,844
+2,315
| +17% | +$95.4K | ﹤0.01% | 2054 |
|
|
2019
Q4 | $579K | Buy |
13,529
+2,895
| +27% | +$126K | ﹤0.01% | 2361 |
|
|
2019
Q3 | $383K | Buy |
+10,634
| New | +$322K | ﹤0.01% | 2516 |
|
|
2019
Q1 | – | Sell |
-10,359
| Closed | -$168K | – | 2953 |
|
|
2018
Q4 | $168K | Buy |
+10,359
| New | +$201K | ﹤0.01% | 2732 |
|
|
2018
Q3 | – | Sell |
-619
| Closed | -$9K | – | 1244 |
|
|
2018
Q2 | $9K | Buy |
619
+87
| +16% | +$1.55K | ﹤0.01% | 2549 |
|
|
2018
Q1 | $12K | Buy |
532
+214
| +67% | +$5.92K | ﹤0.01% | 2460 |
|
|
2017
Q4 | $10K | Sell |
318
-143
| -31% | -$4.57K | ﹤0.01% | 2620 |
|
|
2017
Q3 | $17K | Sell |
461
-1,729
| -79% | -$56.2K | ﹤0.01% | 2513 |
|
|
2017
Q2 | $61K | Sell |
2,190
-1,106
| -34% | -$33K | ﹤0.01% | 2290 |
|
|
2017
Q1 | $113K | Buy |
3,296
+617
| +23% | +$21.8K | ﹤0.01% | 2138 |
|
|
2016
Q4 | $77K | Sell |
2,679
-61
| -2% | -$1.61K | ﹤0.01% | 2283 |
|
|
2016
Q3 | $87K | Sell |
2,740
-994
| -27% | -$33.7K | ﹤0.01% | 2385 |
|
|
2016
Q2 | $121K | Buy |
3,734
+463
| +14% | +$15.5K | ﹤0.01% | 2344 |
|
|
2016
Q1 | $91K | Buy |
3,271
+1,212
| +59% | +$26.4K | ﹤0.01% | 2443 |
|
|
2015
Q4 | $73K | Buy |
2,059
+44
| +2% | +$1.55K | ﹤0.01% | 2502 |
|
|
2015
Q3 | $67K | Buy |
+2,015
| New | +$83.8K | ﹤0.01% | 2517 |
|
|
2014
Q4 | – | Sell |
-38
| Closed | -$1K | – | 2480 |
|
|
2014
Q3 | $1K | Hold |
38
| – | – | ﹤0.01% | 2586 |
|
|
2014
Q2 | $1K | Hold |
38
| – | – | ﹤0.01% | 2565 |
|
|
2014
Q1 | $1K | Buy |
+38
| New | +$961 | ﹤0.01% | 2387 |
|
Other funds holding ACAD
BBA
VPM
RI
VCM
PAI